-
公开(公告)号:US20200179333A1
公开(公告)日:2020-06-11
申请号:US16793861
申请日:2020-02-18
IPC分类号: A61K31/357 , A61K31/343 , A61P27/16
摘要: A method of treating a glycosylation-defective protein associated disease or disorder in a subject, the method includes administering to the subject a therapeutically effective amount of a Sarco/ER ATPase (SERCA) inhibitor.
-
公开(公告)号:US20220168269A1
公开(公告)日:2022-06-02
申请号:US17468274
申请日:2021-09-07
IPC分类号: A61K31/357 , A61P27/16 , A61K31/343
摘要: A method of treating a glycosylation-defective protein associated disease or disorder in a subject, the method includes administering to the subject a therapeutically effective amount of a Sarco/ER ATPase (SERCA) inhibitor.
-
公开(公告)号:US11865103B2
公开(公告)日:2024-01-09
申请号:US17468274
申请日:2021-09-07
IPC分类号: A61K31/12 , A61K31/34 , A61K31/335 , A61K31/435 , A61K33/00 , A61K31/357 , A61P27/16 , A61K31/343
CPC分类号: A61K31/357 , A61K31/343 , A61P27/16
摘要: A method of treating a glycosylation-defective protein associated disease or disorder in a subject, the method includes administering to the subject a therapeutically effective amount of a Sarco/ER ATPase (SERCA) inhibitor.
-
公开(公告)号:US11110076B2
公开(公告)日:2021-09-07
申请号:US16793861
申请日:2020-02-18
IPC分类号: A61K31/12 , A61K31/34 , A61K31/335 , A61K31/435 , A61K33/00 , A61K31/357 , A61P27/16 , A61K31/343
摘要: A method of treating a glycosylation-defective protein associated disease or disorder in a subject, the method includes administering to the subject a therapeutically effective amount of a Sarco/ER ATPase (SERCA) inhibitor.
-
-
-